The current valuation score of Vertex Pharmaceuticals Inc is 9.24, ranking 38 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is 27.45, which is 23.66% below the recent high of 33.95 and 1115.74% above the recent low of -278.85.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.